CoChat

Diabetes and cancer relationships (糖尿病与肿瘤的关联性)

Wang, Tiange, Ning, Guang, Bloomgarden, Zachary · 2013 · Journal of Diabetes
Cited by 21

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Diabetes and cancer are both heterogeneous and multifactorial diseases with tremendous impact on health worldwide. Epidemiologic evidence suggests that certain malignancies may be associated with diabetes, as well as with diabetes risk factors and, perhaps, with certain diabetes treatments. Numerous biological mechanisms could account for these relationships. Insulin‐like growth factor (IGF)‐1, IGF‐2, IGF‐1 receptors, insulin, and the insulin receptor play roles in the development and progression of cancers. Although evidence from randomized controlled trials does not support or refute associations of diabetes and its treatments with either increased or reduced risk of cancer incidence or prognosis, consideration of malignancy incidence rates and the magnitude of the trials that would be required to address these issues explains why such studies may not be readily undertaken.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1753-0407.12057

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 142

  1. 10.1001/jama.293.2.194 · DOI · Paper page
  2. 10.1007/s00125-006-0207-6 · DOI · Paper page
  3. 10.2337/dc06-0922 · DOI · Paper page
  4. Tulinius H, 1997, Risk factors for malignant diseases: A cohort study on a population of 22 946 Icelanders, Cancer Epidemiol Biomarkers Prev, 6, 863
  5. 10.1093/oxfordjournals.aje.a115495 · DOI · Paper page
  6. 10.1093/aje/kwg100 · DOI · Paper page
  7. 10.1371/journal.pmed.1000201 · DOI · Paper page
  8. 10.1002/ijc.22717 · DOI · Paper page
  9. 10.1007/s00125-006-0468-0 · DOI · Paper page
  10. 10.1007/s00125-007-0681-5 · DOI · Paper page
  11. 10.1016/j.cgh.2005.12.007 · DOI · Paper page
  12. 10.1007/s00125-004-1415-6 · DOI · Paper page
  13. 10.1093/aje/kwp003 · DOI · Paper page
  14. 10.1093/aje/kwj311 · DOI · Paper page
  15. 10.1023/A:1011279907108 · DOI
  16. 10.1016/j.ejca.2005.09.003 · DOI · Paper page
  17. 10.1016/j.ijrobp.2009.06.051 · DOI
  18. 10.1038/pcan.2009.39 · DOI
  19. World Cancer Research Fund/American Institute for Cancer Research, 2007, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective
  20. 10.1158/1055-9965.EPI-12-0485 · DOI · Paper page
  21. 10.1016/S0140-6736(08)60269-X · DOI · Paper page
  22. 10.1038/oby.2005.177 · DOI · Paper page
  23. 10.1007/s10549-012-2187-1 · DOI
  24. 10.1038/oby.2008.610 · DOI · Paper page
  25. 10.1097/SLA.0b013e3181e33778 · DOI
  26. 10.1016/j.soard.2008.08.025 · DOI · Paper page
  27. 10.1111/j.1467-789X.2012.01010.x · DOI · Paper page
  28. 10.1080/13813450902878054 · DOI · Paper page
  29. 10.3109/10408368409165766 · DOI · Paper page
  30. 10.1055/s-0031-1295414 · doi:10.1055/s-0031-1295414
  31. 10.1371/journal.pone.0018134 · DOI · Paper page
  32. 10.1016/j.regpep.2008.10.008 · DOI
  33. 10.2337/dc12-1316 · DOI · Paper page
  34. 10.1158/0008-5472.CAN-07-2946 · DOI · Paper page
  35. 10.1158/1055-9965.EPI-07-0182 · DOI · Paper page
  36. 10.1002/ijc.21861 · DOI · Paper page
  37. 10.1093/jnci/djn415 · DOI · Paper page
  38. 10.1002/ijc.22578 · DOI · Paper page
  39. 10.1158/1055-9965.EPI-07-2686 · DOI · Paper page
  40. Muti P, 2002, Fasting glucose is a risk factor for breast cancer: A prospective study, Cancer Epidemiol Biomarkers Prev, 11, 1361
  41. 10.7326/0003-4819-149-7-200810070-00006 · DOI
  42. 10.1016/j.tcb.2008.01.008 · DOI
  43. 10.2337/dc11-0512 · DOI · Paper page
  44. 10.1200/JCO.2011.39.7505 · DOI · Paper page
  45. 10.1007/s10549-012-2170-x · DOI · Paper page
  46. 10.1186/1471-2407-12-410 · DOI · Paper page
  47. 10.1038/ajg.2011.483 · DOI · Paper page
  48. 10.1016/j.ygyno.2011.06.038 · DOI · Paper page
  49. 10.1038/ajg.2013.5 · DOI · Paper page
  50. 10.3109/0284186X.2012.718096 · DOI · Paper page
  51. 10.1093/annonc/mdr020 · DOI
  52. 10.1093/annonc/mdr534 · DOI · Paper page
  53. Kubota T, 1998, Ligand for peroxisome proliferator‐activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo, Cancer Res, 58, 3344
  54. 10.1210/jc.86.5.2170 · doi:10.1210/jc.86.5.2170
  55. 10.1634/theoncologist.2012-0302 · DOI · Paper page
  56. 10.1158/0008-5472.CAN-05-4277 · DOI · Paper page
  57. 10.1038/onc.2011.299 · DOI
  58. 10.1002/hep.23669 · DOI
  59. 10.1038/bjc.2012.130 · DOI
  60. 10.1503/cmaj.112102 · DOI · Paper page
  61. 10.1001/jama.2011.939 · DOI
  62. 10.1111/dme.12144 · DOI · Paper page
  63. 10.2337/dc10-0476 · DOI
  64. 10.2337/dc12-1432 · DOI
  65. 10.2337/db09-1371 · DOI · Paper page
  66. 10.1371/journal.pone.0053411 · DOI · Paper page
  67. 10.1136/bmjopen-2011-000433 · DOI
  68. 10.1210/jc.2012-1162 · DOI · Paper page
  69. 10.1016/j.metabol.2010.09.012 · DOI
  70. 10.1371/journal.pone.0041992 · DOI
  71. 10.2337/dc12-0270 · DOI
  72. 10.1007/s00125-009-1453-1 · DOI · Paper page
  73. 10.1007/s00125-011-2312-4 · DOI
  74. 10.3109/0284186X.2011.624118 · DOI
  75. 10.1007/s00125-011-2429-5 · DOI
  76. 10.1016/S0140-6736(09)61307-6 · DOI
  77. 10.1111/j.1753-0407.2009.00038.x · DOI
  78. 10.1038/nrc3215 · DOI · Paper page
  79. 10.1038/ajg.2013.7 · DOI · Paper page
  80. 10.1016/j.metabol.2013.01.014 · DOI · Paper page
  81. 10.1634/theoncologist.2011-0462 · DOI · Paper page
  82. 10.1016/j.diabres.2010.08.022 · DOI
  83. 10.1016/j.cbi.2006.07.006 · DOI
  84. 10.1007/s00125-012-2653-7 · DOI · Paper page
  85. 10.1007/s00125-010-1804-y · DOI · Paper page
  86. 10.1007/s00125-009-1530-5 · DOI · Paper page
  87. 10.1007/s00125-010-1933-3 · DOI
  88. 10.1056/NEJMoa0802987 · DOI · Paper page
  89. 10.1016/S0140-6736(05)67528-9 · DOI · Paper page
  90. 10.1016/S0140-6736(09)60953-3 · DOI · Paper page
  91. 10.1136/bmj.e5278 · DOI · Paper page
  92. 10.1002/j.1460-2075.1986.tb04528.x · DOI · Paper page
  93. 10.1007/PL00000744 · DOI · Paper page
  94. 10.1158/1078-0432.CCR-07-4879 · DOI · Paper page
  95. 10.1016/S0960-9822(01)00068-9 · DOI · Paper page
  96. 10.1073/pnas.0403328101 · DOI · Paper page
  97. 10.1016/S0968-0004(02)02113-8 · DOI · Paper page
  98. 10.1210/endo.139.3.5832 · doi:10.1210/endo.139.3.5832 · Paper page
  99. 10.1023/A:1009523501499 · DOI · Paper page
  100. 10.1016/j.febslet.2004.08.013 · DOI · Paper page
  101. 10.1038/sj.cdd.4401839 · DOI
  102. 10.1128/MCB.19.5.3278 · DOI · Paper page
  103. 10.1136/mp.54.3.121 · DOI · Paper page
  104. Vella V, 2002, A novel autocrine loop involving IGF‐II and the insulin receptor isoform‐A stimulates growth of thyroid cancer, J Clin Endocrinol Metab, 87, 245, 10.1210/jcem.87.1.8142 · doi:10.1210/jcem.87.1.8142 · Paper page
  105. Mathieu MC, 1997, Insulin receptor expression and clinical outcome in node‐negative breast cancer, Proc Assoc Am Physicians, 109, 565
  106. 10.1002/j.1460-2075.1990.tb07416.x · DOI · Paper page
  107. 10.1016/0006-291X(89)92439-X · DOI · Paper page
  108. 10.1055/s-2004-814157 · DOI
  109. 10.1210/mend-3-8-1263 · DOI · Paper page
  110. 10.1210/me.2004-0183 · DOI · Paper page
  111. 10.1210/mend-5-5-734 · DOI
  112. 10.1210/en.132.3.1132 · doi:10.1210/en.132.3.1132
  113. 10.1210/en.2002-0136 · DOI
  114. 10.1172/JCI115819 · DOI · Paper page
  115. 10.2337/diab.42.5.675 · DOI
  116. 10.1007/BF00403966 · DOI
  117. 10.1371/journal.pone.0027488 · DOI · Paper page
  118. 10.1080/13813450801969715 · DOI · Paper page
  119. 10.1038/sj.onc.1202600 · DOI · Paper page
  120. 10.1038/sj.onc.1206058 · DOI · Paper page
  121. 10.1210/en.2001-211408 · DOI · Paper page
  122. 10.2337/diacare.13.6.576 · doi:10.2337/diacare.13.6.576
  123. 10.1042/bj2900419 · DOI · Paper page
  124. Pandini G, 1999, Insulin and insulin‐like growth factor‐I (IGF‐I) receptor overexpression in breast cancers leads to insulin/IGF‐I hybrid receptor overexpression: Evidence for a second mechanism of IGF‐I signaling, Clin Cancer Res, 5, 1935
  125. 10.1016/S0300-9084(99)80088-1 · DOI
  126. 10.1074/jbc.M202766200 · DOI · Paper page
  127. 10.1002/ijc.22697 · DOI · Paper page
  128. 10.1038/nrc3174 · DOI · Paper page
  129. 10.1056/NEJMoa1006312 · DOI · Paper page
  130. 10.1053/gast.2001.25490 · DOI · Paper page
  131. 10.1136/gut.2010.235754 · DOI · Paper page
  132. 10.1210/jc.2004-0297 · DOI
  133. 10.1074/jbc.M313191200 · DOI · Paper page
  134. 10.1016/j.bbapap.2009.09.012 · DOI · Paper page
  135. 10.1371/journal.pone.0004968 · DOI
  136. 10.1074/jbc.275.17.12565 · DOI
  137. 10.1007/s12032-012-0198-8 · doi:10.1007/s12032-012-0198-8
  138. Osborne CK, 2005, Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer, Clin Cancer Res, 11, 865s, 10.1158/1078-0432.865s.11.2 · DOI · Paper page
  139. 10.3109/08977194.2011.565003 · DOI
  140. 10.1016/j.mce.2004.08.002 · DOI
  141. 10.1074/jbc.M109592200 · DOI · Paper page
  142. 10.1038/nrc1408 · DOI · Paper page

Cited by

See all 21

Metadata

Authors
Wang, T., Ning, G., & Bloomgarden, Z.
Venue
Journal of Diabetes
Publisher
Wiley
Published
2013-06-05
Volume
5
Issue
4
Pages
378-390
ISSN
  • 1753-0393 (ISSN-L)
  • 1753-0407
OpenAlex
W1492825867
Cited by
21
References
24
FWCI
1.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.